The effects of clozapine and risperidone on spatial working memory in schizophrenia

American Journal of Psychiatry

Volumn 162, Issue 5, 2005, Pages 1013-1016

  McGurk, Susan R ^a   Carter, Cameron ^b   Goldman, Robert ^b   Green, Michael F ^b   Marder, Stephen R ^b   Xie, Haiyi ^b   Schooler, Nina R ^b   Kane, John M ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; DOPAMINE; RISPERIDONE;

ADULT; ANTICHOLINERGIC EFFECT; ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG WITHDRAWAL; EMOTION; FEMALE; HALLUCINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; SCORING SYSTEM; SPATIAL MEMORY; TASK PERFORMANCE; WORKING MEMORY;

ADULT; ANTIPSYCHOTIC AGENTS; BRIEF PSYCHIATRIC RATING SCALE; CLOZAPINE; DIAGNOSIS, COMPUTER-ASSISTED; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEMORY; MEMORY DISORDERS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PREFRONTAL CORTEX; PSYCHOMOTOR PERFORMANCE; PSYCHOTIC DISORDERS; RISPERIDONE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SPACE PERCEPTION;

EID: 18744403077     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.162.5.1013     Document Type: Article

References (23)

1. Wilson FA, O'Scalaidhe SP, Goldman-Rakic PS: Dissociation of object and spatial processing domains in primate prefrontal cortex. Science 1993; 260:1955-1958
2. Carter CS, Perlstein W, Ganguli R, Brar J, Mintun M, Cohen JD: Functional hypofrontality and working memory dysfunction in schizophrenia. Am J Psychiatry 1998; 155:1285-1287
3. Park S, Holzman P: Schizophrenics show spatial working memory deficits. Arch Gen Psychiatry 1992; 49:975-982
4. Keefe RSE, Lees Roitman SE, Harvey PD, Blum CS, DuPre RL, Prieto DM, Davidson M, Davis KL: A pen-and-paper human analogue of a monkey prefrontal cortex activation task: spatial working memory in patients with schizophrenia. Schizophr Res 1995; 17:25-33
5. Park S, Holzman PS, Goldman-Rakic PS: Spatial working memory deficits in the relatives of schizophrenic patients. Arch Gen Psychiatry 1995; 52:821-828
6. Glahn DC, Therman S, Manninen M, Huttunen M, Kaprio J, Lonnqvist J, Cannon TD: Spatial working memory as an endophenotype for schizophrenia. Biol Psychiatry 2003; 53:624-626
7. McGurk SR, Meltzer HY: The role of cognition in vocational functioning in schizophrenia. Schizophr Res 2000; 45:175-184
8. McGurk SR, Green MF, Wirshing WC, Ames D, Marshall BD, Kern R, Marder SM: Antipsychotic and anticholinergic effects on two types of spatial memory in schizophrenia. Schizophr Res 2004; 68:225-233
9. Snyder S, Greenberg D, Yamamura HI: Antischizophrenic drugs and brain cholinergic receptors: affinity for muscarinic sites predicts extra pyramidal effects. Arch Gen Psychiatry 1974; 31: 58-71
10. Bolden C, Cusack B, Richelson E: Antagonism by antimuscarinics and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors cloned on hamster ovary cells. J Pharmacol Exp Ther 1992; 260:576-580
11. Goldberg TE, Weinberger DR: The effects of clozapine on neurocognition: an overview. J Clin Psychiatry 1994; 55(9, suppl B): 88-90
12. Hoff AL, Faustman WO, Wieneke M, Espinoza S, Costa M, Wolkowitz O, Csernansky JG: The effects of clozapine on symptom reduction, neurocognitive function, and clinical management in treatment-refractory state hospital schizophrenic in-patients. Neuropsychopharmacology 1996; 15:361-369
13. Hagger C, Buckley P, Kenny JT, Friedman L, Ubogy D, Meltzer HY: Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine. Biol Psychiatry 1993; 34:702-712
14. Bilder RM, Goldman RS, Volavka J, Czobor P, Hoptman M, Sheitman B, Lindenmayer J-P, Citrome L, McEvoy J, Kunz M, Chakos M, Cooper TB, Horowitz TL, Lieberman JA: Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. Am J Psychiatry 2002; 159:1018-1028
15. Castner SA, Williams GV, Goldman-Rakic PS: Reversal of antipsychotic-induced working memory deficits by short-term dopamine D1 receptor stimulation. Science 2000; 287:2020-2022
16. Green MF, Marshall BD Jr, Wirshing WC, Ames D, Marder SR, McGurk S, Kern RS, Mintz J: Does risperidone improve verbal working memory in treatment-resistant schizophrenia? Am J Psychiatry 1997; 154:799-804
17. Schotte A, Janssen PFM, Gommeren W, Luyten W, Van Grompel P, Lesage AS, De Loore K, Leysen JE: Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology (Berl) 1996; 124: 57-73
18. Bellack AS, Schooler NR, Marder SR, Kane JM, Brown CH, Yang Y: Do clozapine and risperidone affect social competence and problem solving? Am J Psychiatry 2004; 161:364-367
19. Overall JE, Gorham DR: The Brief Psychiatric Rating Scale. Psychol Rep 1962; 10:799-812
20. Andreasen NC: Modified Scale for the Assessment of Negative Symptoms (SANS). Iowa City, University of Iowa, 1984
21. Laird NM, Ware JH: Random effects models for longitudinal data. Biometrics 1982; 38:963-974
22. SAS System for Mixed Models. Cary, NC, SAS Institute, 1996
23. Bartus RT, Johnson HR: Short-term memory in the rhesus monkey: disruption from the anti-cholinergic scopolamine. Pharmacol Biochem Behav 1976; 5:39-46